Credit Suisse’s iTeos Therapeutics ITOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $364K | Hold |
26,661
| – | – | ﹤0.01% | 2760 |
|
|
2023
Q4 | $292K | Buy |
26,661
+7,756
| +41% | +$84.9K | ﹤0.01% | 2912 |
|
|
2023
Q3 | $207K | Sell |
18,905
-4,512
| -19% | -$49.4K | ﹤0.01% | 3015 |
|
|
2023
Q2 | $310K | Buy |
23,417
+553
| +2% | +$7.32K | ﹤0.01% | 2981 |
|
|
2023
Q1 | $311K | Buy |
22,864
+1,608
| +8% | +$21.9K | ﹤0.01% | 2967 |
|
|
2022
Q4 | $415K | Sell |
21,256
-539
| -2% | -$10.5K | ﹤0.01% | 2874 |
|
|
2022
Q3 | $415K | Buy |
21,795
+12,605
| +137% | +$240K | ﹤0.01% | 2883 |
|
|
2022
Q2 | $189K | Sell |
9,190
-1,117
| -11% | -$23K | ﹤0.01% | 3335 |
|
|
2022
Q1 | $331K | Sell |
10,307
-1,195
| -10% | -$38.4K | ﹤0.01% | 3162 |
|
|
2021
Q4 | $535K | Buy |
+11,502
| New | +$535K | ﹤0.01% | 2977 |
|
|
2021
Q2 | – | Sell |
-8,912
| Closed | -$304K | – | 3618 |
|
|
2021
Q1 | $304K | Sell |
8,912
-24,584
| -73% | -$839K | ﹤0.01% | 3151 |
|
|
2020
Q4 | $1.13M | Buy |
+33,496
| New | +$1.13M | ﹤0.01% | 2498 |
|